zPREDICTA
acquired by Predictive OncologyYC S15 ↗San Francisco, US · Founded 2014 · 2 employees · 1 known investors
zPREDICTA manufactures three-dimensional tissue culture models derived from patient samples that recreate human organ microenvironments for drug testing. Pharmaceutical companies and researchers use the models to evaluate cancer drug candidates and predict clinical efficacy before human trials.
Founders & leadership· Y Combinator alumni (S15)
MP
Mukti ParikhFounder/CTO
Investors · 1
In the news
- Predictive Oncology Acquires zPREDICTA, Inc.globenewswire.com · 2021